NCT03263091Phase 3Terminated

Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

Study sponsor: Kyntra Bio

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-03-09Actual
Enrollment · participants184Actual
Source updated2024-08-01Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview